Results from the REDUCE-IT trial suggest that combining statins with eicosapentaenoic acid, a component of fish oil, reduces the risk of heart attack, stroke, angina, and bypass or stent surgery. Vascepa was approved as therapy to reduce the risk of cardiovascular events based on these findings.
Read more
N. R. Gough, Statin Plus Icosapent, A Recipe for Reducing Cardiovascular Disease Risk. BioSerendipity (29 October 2019) https://www.bioserendipity.com/statin-plus-icosapent,-a-recipe-for-reducing-cardiovascular-disease-risk/https://www.bioserendipity.com/statin-plus-icosapent,-a-recipe-for-reducing-cardiovascular-disease-risk/
N. R. Gough, A Recipe for Reducing Cardiovascular Disease Risk